All persons or entities that purchased or otherwise acquired common shares of Depomed, Inc., n/k/a Assertio Therapeutics, Inc. (“Depomed” or the “Company”) from July 29, 2015 to August 7, 2017, inclusive.
Disbursed
July 28, 2015 - August 07, 2017
July 28, 2022
July 07, 2022
Analytics Consulting, LLC
Depomed (n/k/a Assertio Therapeutics) Securities Litigation
c/o Analytics Consulting LLC
P.O. Box 2004
Chanhassen, MN 55317-2004
+1 866-327-1934
info@DepomedSecuritiesLitigation.com
Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.